IHS Chemical Week

Regions :: India/Pakistan

CPhI: Dr. Reddy’s builds large-scale API facility in India

11:13 AM MDT | October 16, 2012 | Deepti Ramesh in Madrid

Dr. Reddy’s Laboratories (Hyderabad, India), the second largest API company in the world in terms of sales, after Teva, says that it will open a new large-scale active pharmaceutical ingredient (API) manufacturing facility at Visakhapatnam, India later this year. The current global API manufacturing operations of Dr. Reddy’s include six plants in India; one plant at Mirfield, UK; and a plant at Cuernavaca, Mexico. All the facilities are approved by the US FDA. “As we grow we need production capacity to support this growth. Later this year, we...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa